Invitae Wants Myriad's Gene-Testing Patent Suit Tossed
Genetic testing company Invitae Corp. asked a Utah federal court Monday to throw out Myriad Genetics Inc.'s suit alleging Invitae infringed on its patents relating to genetic screening for breast cancer,...To view the full article, register now.
Already a subscriber? Click here to view full article